CTOR
Citius Oncology, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.86
+8.56%Next report
Analyst consensus
- Next report date
- Dec 17, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- $5.8M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.07
- Revenue actual
- $1.5M
- Revenue estimate
- $2.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -666.1%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 17, 2026